FDA adds rare vision-loss warning to popular GLP-1 drugs
· newsday.com · popularity 11/100 · 1 similar story today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at newsday.com →
Summary
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic.
Found in: Newsday. Rating basis: 1 other outlets; outlet tier 2 (unlisted); 1 feeds; feed position 139.